Rupali Bhave

553 total citations
18 papers, 168 citations indexed

About

Rupali Bhave is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Rupali Bhave has authored 18 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Molecular Biology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Rupali Bhave's work include Acute Myeloid Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). Rupali Bhave is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). Rupali Bhave collaborates with scholars based in United States, Italy and Israel. Rupali Bhave's co-authors include Timothy S. Pardee, Bayard L. Powell, Leslie R. Ellis, Sarah Dralle, Susan Lyerly, Dianna S. Howard, Megan Manuel, Kah Poh Loh, Janet A. Tooze and Heidi D. Klepin and has published in prestigious journals such as Nature Communications, Blood and Cancer.

In The Last Decade

Rupali Bhave

15 papers receiving 168 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rupali Bhave United States 6 86 67 49 46 21 18 168
Nadia Raban France 7 32 0.4× 43 0.6× 19 0.4× 62 1.3× 22 1.0× 17 145
Tuong Vi Nguyen Australia 11 117 1.4× 128 1.9× 29 0.6× 75 1.6× 29 1.4× 18 303
Francesca Ferrara Italy 6 105 1.2× 220 3.3× 13 0.3× 19 0.4× 17 0.8× 9 290
Raffaella Grasso Italy 8 181 2.1× 111 1.7× 87 1.8× 34 0.7× 22 1.0× 22 235
Shlomzion Aumann Israel 7 53 0.6× 97 1.4× 25 0.5× 51 1.1× 21 1.0× 25 160
Alyssa Clay‐Gilmour United States 8 38 0.4× 44 0.7× 28 0.6× 28 0.6× 24 1.1× 17 132
Maria Chiara Abbenante Italy 7 83 1.0× 80 1.2× 66 1.3× 45 1.0× 24 1.1× 27 173
Maria López‐Pavía Spain 9 108 1.3× 102 1.5× 31 0.6× 21 0.5× 35 1.7× 21 183
Clarissa Kooi Netherlands 6 105 1.2× 100 1.5× 132 2.7× 42 0.9× 27 1.3× 7 254
Valeria Calafiore Italy 7 149 1.7× 37 0.6× 62 1.3× 38 0.8× 5 0.2× 21 214

Countries citing papers authored by Rupali Bhave

Since Specialization
Citations

This map shows the geographic impact of Rupali Bhave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupali Bhave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupali Bhave more than expected).

Fields of papers citing papers by Rupali Bhave

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupali Bhave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupali Bhave. The network helps show where Rupali Bhave may publish in the future.

Co-authorship network of co-authors of Rupali Bhave

This figure shows the co-authorship network connecting the top 25 collaborators of Rupali Bhave. A scholar is included among the top collaborators of Rupali Bhave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupali Bhave. Rupali Bhave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pardee, Timothy S., Rupali Bhave, Leslie R. Ellis, et al.. (2024). The Impact of Weight Loss Grading Scale, a Measure of Cancer Cachexia, on Clinical Outcomes in Patients with Acute Myeloid Leukemia. Blood. 144(Supplement 1). 2858–2858.
2.
Bhave, Rupali, Ruben A. Mesa, & Michael R. Grunwald. (2023). Top advances of the year: Myeloproliferative neoplasms. Cancer. 129(23). 3685–3691.
3.
Reed, Daniel, Scott Isom, Leslie R. Ellis, et al.. (2023). Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen. Annals of Hematology. 102(4). 897–906.
4.
Anderson, Rebecca G., Lance D. Miller, Scott Isom, et al.. (2022). Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia. Nature Communications. 13(1). 1673–1673. 28 indexed citations
5.
Vincent, T., Lydia L. Benitez, Anthony J. Perissinotti, et al.. (2021). Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform. Cancer Genetics. 258-259. 57–60. 4 indexed citations
6.
Woods, R., Leslie R. Ellis, Rupali Bhave, et al.. (2021). A Pilot Phase II Study of the Feasibility and Efficacy of Vincristine Sulfate Liposome Injection in Patients With Relapsed or Refractory Acute Myeloid Leukemia. Journal of Hematology. 10(1). 1–7. 2 indexed citations
7.
Mehta, Vivek, Scott Isom, Leslie R. Ellis, et al.. (2021). Efficacy of 10-day decitabine in acute myeloid leukemia. Leukemia Research. 103. 106524–106524. 5 indexed citations
8.
Dralle, Sarah, Megan Manuel, Susan Lyerly, et al.. (2021). Incidence of Breakthrough Fungal Infections in Acute Myeloid Leukemia Patients Receiving Low Intensity Therapy in the Upfront and Relapsed/Refractory Setting. Blood. 138(Supplement 1). 3372–3372. 3 indexed citations
9.
Loh, Kah Poh, Janet A. Tooze, Timothy S. Pardee, et al.. (2020). Geriatric assessment and survival among older adults receiving postremission therapy for acute myeloid leukemia. Blood. 136(23). 2715–2719. 34 indexed citations
10.
Pardee, Timothy S., Susan Lyerly, Sarah Dralle, et al.. (2020). Frontline Selinexor and Chemotherapy Is Highly Active in Older Adults with Acute Myeloid Leukemia (AML). Blood. 136(Supplement 1). 24–25. 4 indexed citations
11.
Goldberg, Aaron D., Mark B. Geyer, Jonathan Kell, et al.. (2020). Clinical Benefit of Crenolanib, with or without Salvage Chemotherapy, in Multiply Relapsed, FLT3 Mutant AML Patients after Prior Treatment with Gilteritinib. Blood. 136(Supplement 1). 8–9. 5 indexed citations
12.
Mascarenhas, John, Heidi Kosiorek, Lilian Varricchio, et al.. (2020). Rationale for and Results of a Phase I Study of the TGF-β 1/3 Inhibitor AVID200 in Subjects with Myelofibrosis: MPN-RC 118 Trial. Blood. 136(Supplement 1). 6–8. 8 indexed citations
13.
Pardee, Timothy S., Kris C. Wood, Kevin Lin, et al.. (2019). Selinexor in Combination with Induction and Consolidation Therapy in Older Adults with AML Is Highly Active. Blood. 134(Supplement_1). 1388–1388. 3 indexed citations
14.
15.
16.
17.
Pardee, Timothy S., Scott Isom, Leslie R. Ellis, et al.. (2017). Interim Analysis of a Single Arm Phase II Study of Cpi-613 in Combination with High Dose Cytarabine and Mitoxantrone for Patients with Relapsed or Refractory AML. Blood. 130. 2626–2626. 1 indexed citations
18.
Li, Fengyin, Bing He, Xiaoke Ma, et al.. (2017). Prostaglandin E1 and Its Analog Misoprostol Inhibit Human CML Stem Cell Self-Renewal via EP4 Receptor Activation and Repression of AP-1. Cell stem cell. 21(3). 359–373.e5. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadia Raban Breakdown of academic impact, for papers by Tuong Vi Nguyen Breakdown of academic impact, for papers by Francesca Ferrara Breakdown of academic impact, for papers by Raffaella Grasso Breakdown of academic impact, for papers by Shlomzion Aumann Breakdown of academic impact, for papers by Alyssa Clay‐Gilmour Breakdown of academic impact, for papers by Maria Chiara Abbenante Breakdown of academic impact, for papers by Maria López‐Pavía Breakdown of academic impact, for papers by Clarissa Kooi Breakdown of academic impact, for papers by Valeria Calafiore
Rankless by CCL
2026